Resilient emotionality and molecular compensation in mice lacking the oligodendrocyte-specific gene Cnp1

Translational Psychiatry

Volumn 1, Issue , 2011, Pages

  Edgar, N M ^a   Touma, C ^b   Palme, R ^c   Sibille, E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

Cnp; depression; myelin; oligodendrocyte; stress; UCMS

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; CNP PROTEIN, MOUSE;

ANIMAL; ARTICLE; C57BL MOUSE; CHRONIC DISEASE; COHORT ANALYSIS; DISEASE MODEL; EMOTION; FEMALE; GENETICS; MAJOR DEPRESSION; MALE; MENTAL STRESS; MOUSE; MOUSE MUTANT; OLIGODENDROGLIA; PHYSIOLOGY; PREDICTIVE VALUE; PSYCHOLOGICAL ASPECT; RANDOMIZATION;

2',3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE; ANIMALS; CHRONIC DISEASE; COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; DISEASE MODELS, ANIMAL; EMOTIONS; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGODENDROGLIA; PREDICTIVE VALUE OF TESTS; RANDOM ALLOCATION; STRESS, PSYCHOLOGICAL;

EID: 80053261306     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2011.40     Document Type: Article

References (73)

1. Fields RD. Central role of glia in disease research. Neuron Glia Biol 2010; 6: 91-92.
2. Fields RD. White matter in learning, cognition and psychiatric disorders. Trends Neurosci 2008; 31: 361-370.
3. Hercher C, Turecki G, Mechawar N. Through the looking glass: Examining neuroanatomical evidence for cellular alterations in major depression. J Psychiatr Res 2009; 43: 947-961.
4. Steiner J, Bielau H, Brisch R, Danos P, Ullrich O, Mawrin C et al. Immunological aspects in the neurobiology of suicide: Elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res 2008; 42: 151-157. (Pubitemid 350061255)
5. Muller N, Schwarz MJ. The immune-mediated alteration of serotonin and glutamate: Towards an integrated view of depression. Mol Psychiatry 2007; 12: 988-1000. (Pubitemid 350006207)
6. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009; 65: 732-741.
7. Banasr M, Chowdhury GM, Terwilliger R, Newton SS, Duman RS, Behar KL et al. Glial pathology in an animal model of depression: Reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Mol Psychiatry 2010; 15: 501-511.
8. Choudary PV, Molnar M, Evans SJ, Tomita H, Li JZ, Vawter MP et al. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proc Natl Acad Sci USA 2005; 102: 15653-15658. (Pubitemid 41528111)
9. Rajkowska G, Miguel-Hidalgo JJ. Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets 2007; 6: 219-233. (Pubitemid 46916253)
10. Valentine GW, Sanacora G. Targeting glial physiology and glutamate cycling in the treatment of depression. Biochem Pharmacol 2009; 78: 431-439.
11. Hamidi M, Drevets WC, Price JL. Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes. Biol Psychiatry 2004; 55: 563-569. (Pubitemid 38315029)
12. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: A study from the Stanley Neuropathology Consortium. Schizophr Res 2004; 67: 269-275. (Pubitemid 38251458)
13. Sibille E, Wang Y, Joeyen-Waldorf J, Gaiteri C, Surget A, Oh S et al. A molecular signature of depression in the amygdala. Am J Psychiatry 2009; 166: 1011-1024.
14. Aston C, Jiang L, Sokolov BP. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol Psychiatry 2005; 10: 309-322. (Pubitemid 40432684)
15. Belachew S, Yuan X, Gallo V. Unraveling oligodendrocyte origin and function by cell-specific transgenesis. Dev Neurosci 2001; 23: 287-298. (Pubitemid 34045223)
16. Mallon BS, Shick HE, Kidd GJ, Macklin WB. Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development. J Neurosci 2002; 22: 876-885. (Pubitemid 34141768)
17. Banasr M, Valentine GW, Li XY, Gourley SL, Taylor JR, Duman RS. Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat. Biol Psychiatry 2007; 62: 496-504. (Pubitemid 47284039)
18. Wennstrom M, Hellsten J, Ekstrand J, Lindgren H, Tingstrom A. Corticosterone-induced inhibition of gliogenesis in rat hippocampus is counteracted by electroconvulsive seizures. Biol Psychiatry 2006; 59: 178-186. (Pubitemid 43117508)
19. Alonso G. Prolonged corticosterone treatment of adult rats inhibits the proliferation of oligodendrocyte progenitors present throughout white and gray matter regions of the brain. Glia 2000; 31: 219-231.
20. Wennstrom M, Hellsten J, Ekdahl CT, Tingstrom A. Electroconvulsive seizures induce proliferation of NG2-expressing glial cells in adult rat hippocampus. Biol Psychiatry 2003; 54: 1015-1024. (Pubitemid 37415036)
21. Wennstrom M, Hellsten J, Tingstrom A. Electroconvulsive seizures induce proliferation of NG2-expressing glial cells in adult rat amygdala. Biol Psychiatry 2004; 55: 464-471. (Pubitemid 38338533)
22. Surget A, Wang Y, Leman S, Ibarguen-Vargas Y, Edgar N, Griebel G et al. Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal. Neuropsychopharmacology 2008; 34: 1363-1380.
23. Sequeira A, Mamdani F, Ernst C, Vawter MP, Bunney WE, Lebel V et al. Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS One 2009; 4: E6585.
24. Peirce TR, Bray NJ, Williams NM, Norton N, Moskvina V, Preece A et al. Convergent evidence for 20,30-cyclic nucleotide 30-phosphodiesterase as a possible susceptibility gene for schizophrenia. Arch Gen Psychiatry 2006; 63: 18-24. (Pubitemid 43040014)
25. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 2001; 98: 4746-4751. (Pubitemid 32295047)
26. Che R, Tang W, Zhang J, Wei Z, Zhang Z, Huang K et al. No relationship between 20,30-cyclic nucleotide 30-phosphodiesterase and schizophrenia in the Chinese Han population: An expression study and meta-analysis. BMC Med Genet 2009; 10: 31.
27. Braun PE, Lee J, Gravel M. 20, 30-cyclic nucleotide 30-phosphodiesterase: Structure, biology, and function. In: Lazzarini RA (ed). Myelin Biology and Disorders 2, vol. 2. Elsevier Academic Press: London, 2004, pp 499-516.
28. Trapp BD, Bernier L, Andrews SB, Colman DR. Cellular and subcellular distribution of 20,30-cyclic nucleotide 30-phosphodiesterase and its mRNA in the rat central nervous system. J Neurochem 1988; 51: 859-868.
29. Gravel M, Robert F, Kottis V, Gallouzi IE, Pelletier J, Braun PE. 20,30-Cyclic nucleotide 30-phosphodiesterase: A novel RNA-binding protein that inhibits protein synthesis. J Neurosci Res 2009; 87: 1069-1079.
30. Edgar JM, McLaughlin M, Werner HB, McCulloch MC, Barrie JA, Brown A et al. Early ultrastructural defects of axons and axon-glia junctions in mice lacking expression of Cnp1. Glia 2009; 57: 1815-1824.
31. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE et al. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 2003; 33: 366-374. (Pubitemid 36278853)
32. Nave KA. Myelination and the trophic support of long axons. Nat Rev Neurosci 2010; 11: 275-283.
33. Guilloux JP, Seney M, Edgar N, Sibille E. Integrated behavioral z-scoring increases the sensitivity and reliability of behavioral phenotyping in mice: Relevance to emotionality and sex. J Neurosci Methods 2011; 197: 21-31.
34. Siegle GJ, Steinhauer SR, Thase ME, Stenger VA, Carter CS. Can't shake that feeling: Event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. Biol Psychiatry 2002; 51: 693-707. (Pubitemid 34450805)
35. Joeyen-Waldorf J, Edgar N, Sibille E. The roles of sex and serotonin transporter levels in age-and stress-related emotionality in mice. Brain Res 2009; 1286: 84-93.
36. Goldman JM, Murr AS, Cooper RL. The rodent estrous cycle: Characterization of vaginal cytology and its utility in toxicological studies. Birth Defects Res B Dev Reprod Toxicol 2007; 80: 84-97. (Pubitemid 46762318)
37. Sibille E, Sarnyai Z, Benjamin D, Gal J, Baker H, Toth M. Antisense inhibition of 5-hydroxytryptamine2a receptor induces an antidepressant-like effect in mice. Mol Pharmacol 1997; 52: 1056-1063. (Pubitemid 28013724)
38. Sierra-Mercado D, Padilla-Coreano N, Quirk GJ. Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear. Neuropsychopharmacology 2011; 36: 529-538.
39. Sibille E, Arango V, Joeyen-Waldorf J, Wang Y, Leman S, Surget A et al. Large-scale estimates of cellular origins of mRNAs: Enhancing the yield of transcriptome analyses. J Neurosci Methods 2008; 167: 198-206. (Pubitemid 350235629)
40. Rasband MN, Tayler J, Kaga Y, Yang Y, Lappe-Siefke C, Nave KA et al. CNP is required for maintenance of axon-glia interactions at nodes of Ranvier in the CNS. Glia 2005; 50: 86-90. (Pubitemid 40516823)
41. Conti LH, Jirout M, Breen L, Vanella JJ, Schork NJ, Printz MP. Identification of quantitative trait Loci for anxiety and locomotion phenotypes in rat recombinant inbred strains. Behav Genet 2004; 34: 93-103. (Pubitemid 38141756)
42. Holmes A, Murphy DL, Crawley JN. Abnormal behavioral phenotypes of serotonin transporter knockout mice: Parallels with human anxiety and depression. Biol Psychiatry 2003; 54: 953-959. (Pubitemid 37415031)
43. Homberg J, Nijman IJ, Kuijpers S, Cuppen E. Identification of genetic modifiers of behavioral phenotypes in serotonin transporter knockout rats. BMC Genet 2010; 11: 37.
44. Feder A, Nestler EJ, Charney DS. Psychobiology and molecular genetics of resilience. Nat Rev Neurosci 2009; 10: 446-457.
45. Southwick SM, Vythilingam M, Charney DS. The psychobiology of depression and resilience to stress: Implications for prevention and treatment. Annu Rev Clin Psychol 2005; 1: 255-291. (Pubitemid 43843952)
46. Kobasa SC. Stressful life events, personality, and health: An inquiry into hardiness. J Pers Soc Psychol 1979; 37: 1-11.
47. Tugade MM, Fredrickson BL. Resilient individuals use positive emotions to bounce back from negative emotional experiences. J Pers Soc Psychol 2004; 86: 320-333. (Pubitemid 38254768)
48. Herry C, Trifilieff P, Micheau J, Luthi A, Mons N. Extinction of auditory fear conditioning requires MAPK/ERK activation in the basolateral amygdala. Eur J Neurosci 2006; 24: 261-269. (Pubitemid 44050685)
49. Sotres-Bayon F, Bush DE, LeDoux JE. Acquisition of fear extinction requires activation of NR2B-containing NMDA receptors in the lateral amygdala. Neuropsychopharmacology 2007; 32: 1929-1940. (Pubitemid 47258512)
50. Jovanovic T, Ressler KJ. How the neurocircuitry and genetics of fear inhibition may inform our understanding of PTSD. Am J Psychiatry 2010; 167: 648-662.
51. Delgado MR, Nearing KI, Ledoux JE, Phelps EA. Neural circuitry underlying the regulation of conditioned fear and its relation to extinction. Neuron 2008; 59: 829-838.
52. Liberzon I, Sripada CS. The functional neuroanatomy of PTSD: A critical review. Prog Brain Res 2008; 167: 151-169.
53. Shen Y, Meri S. Yin and Yang: Complement activation and regulation in Alzheimer's disease. Prog Neurobiol 2003; 70: 463-472. (Pubitemid 37249427)
54. Katsel P, Tan W, Haroutunian V. Gain in brain immunity in the oldest-old differentiates cognitively normal from demented individuals. PLoS One 2009; 4: E7642.
55. Gonzalez-Rey E, Chorny A, Robledo G, Delgado M. Cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia. J Exp Med 2006; 203: 563-571.
56. van Hagen PM, Dalm VA, Staal F, Hofland LJ. The role of cortistatin in the human immune system. Mol Cell Endocrinol 2008; 286: 141-147.
57. Carrasco E, Hernandez C, de Torres I, Farres J, Simo R. Lowered cortistatin expression is an early event in the human diabetic retina and is associated with apoptosis and glial activation. Mol Vis 2008; 14: 1496-1502.
58. Tsuda M, Kitagawa K, Imaizumi K, Wanaka A, Tohyama M, Takagi T. Induction of SPI-3 mRNA, encoding a serine protease inhibitor, in gerbil hippocampus after transient forebrain ischemia. Brain Res Mol Brain Res 1996; 35: 314-318. (Pubitemid 26036761)
59. Takamiya A, Takeda M, Yoshida A, Kiyama H. Inflammation induces serine protease inhibitor 3 expression in the rat pineal gland. Neuroscience 2002; 113: 387-394. (Pubitemid 34786183)
60. Rao JS, Harry GJ, Rapoport SI, Kim HW. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry 2010; 15: 384-392.
61. Ryan MM, Lockstone HE, Huffaker SJ, Wayland MT, Webster MJ, Bahn S. Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Mol Psychiatry 2006; 11: 965-978. (Pubitemid 44470218)
62. Shelton RC, Claiborne J, Sidoryk-Wegrzynowicz M, Reddy R, Aschner M, Lewis DA et al. Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry 2010; 16: 751-762.
63. Chwastiak LA, Ehde DM. Psychiatric issues in multiple sclerosis. Psychiatr Clin North Am 2007; 30: 803-817. (Pubitemid 47552650)
64. Hogancamp WE, Rodriguez M, Weinshenker BG. Identification of multiple sclerosisassociated genes. Mayo Clin Proc 1997; 72: 965-976.
65. Konradi C, Sillivan SE, Clay HB. Mitochondria, oligodendrocytes and inflammation in bipolar disorder: Evidence from transcriptome studies points to intriguing parallels with multiple sclerosis. Neurobiol Dis 2011 (in press).
66. Poliak S, Peles E. The local differentiation of myelinated axons at nodes of Ranvier. Nat Rev Neurosci 2003; 4: 968-980. (Pubitemid 37486673)
67. Garcia-Fresco GP, Sousa AD, Pillai AM, Moy SS, Crawley JN, Tessarollo L et al. Disruption of axo-glial junctions causes cytoskeletal disorganization and degeneration of Purkinje neuron axons. Proc Natl Acad Sci USA 2006; 103: 5137-5142.
68. Rosenbluth J. Multiple functions of the paranodal junction of myelinated nerve fibers. J Neurosci Res 2009; 87: 3250-3258.
69. Yamazaki Y, Hozumi Y, Kaneko K, Sugihara T, Fujii S, Goto K et al. Modulatory effects of oligodendrocytes on the conduction velocity of action potentials along axons in the alveus of the rat hippocampal CA1 region. Neuron Glia Biol 2007; 3: 325-334. (Pubitemid 351944153)
70. Karadottir R, Hamilton NB, Bakiri Y, Attwell D. Spiking and nonspiking classes of oligodendrocyte precursor glia in CNS white matter. Nat Neurosci 2008; 11: 450-456. (Pubitemid 351441876)
71. Fields RD. Oligodendrocytes changing the rules: Action potentials in glia and oligodendrocytes controlling action potentials. Neuroscientist 2008; 14: 540-543.
72. Yamazaki Y, Hozumi Y, Kaneko K, Fujii S, Goto K, Kato H. Oligodendrocytes: Facilitating axonal conduction by more than myelination. Neuroscientist 2010; 16: 11-18.
73. Edgar JM, Nave KA. The role of CNS glia in preserving axon function. Curr Opin Neurobiol 2009; 19: 498-504.